Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. You look at survival for patients with ...

Multiple myeloma treatment has advanced with new therapies, increasing life expectancy from under 3 years to over a decade. Health disparities persist, with Black patients facing higher diagnosis ...

Smoldering multiple myeloma is an asymptomatic, precancerous condition with abnormal plasma cells and elevated monoclonal protein levels. Smoldering multiple myeloma is a complex, intermediary stage ...

DVRd therapy significantly improves MRD negativity and PFS, showing potential as a frontline treatment for NDMM patients who are transplant-ineligible or deferred. The CEPHEUS trial highlights DVRd's ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Joseph Mikhael, MD ...